Sort
53,477 grants matching “addiction”
Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia
$812,500Dolores Albarracin · University Of Pennsylvania · DP1 · FY2023 · DA
Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia
$812,500Dolores Albarracin · University Of Pennsylvania · DP1 · FY2022 · DA
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$812,387Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2018 · DA
MAPPING OF SUSCEPTIBILITY LOCI FOR NICOTINE DEPENDENCE
$812,306University Of Tennessee Health Sci Ctr · R01 · FY2000 · DA
Location-Based Monitoring and Intervention for Alcohol Use Disorders
$812,278Patrick L Dulin · University Of Alaska Anchorage · RC2 · FY2010 · AA
Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH)
$812,212Katherine Sanchez · University Of Texas Arlington · U01 · FY2023 · MD
Better Outcomes for Children: Promoting Excellence in Healthcare Genomics to Inform Policy
$811,897John Barker Harley · Cincinnati Childrens Hosp Med Ctr · U01 · FY2017 · HG
Second-generation Gene Transfer Vector-based Anti-cocaine Vaccines
$811,852Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · DA
Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
$811,835Chang-Guo Zhan · University Of Kentucky · UH3 · FY2019 · DA
Novel PET imaging agents for understanding glutamine addiction in cancer
$811,646Hank F Kung · University Of Pennsylvania · R01 · FY2015 · CA
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.
$811,478Amy Lynn Baxter · Mmj Labs, Llc · R44 · FY2020 · DA
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
$811,286Jed E Rose · Duke University · R01 · FY2016 · DA
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
$811,238Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2019 · DA
Substance Abuse Treatment to HIV Care (SAT2HIV)
$811,185Bryan R Garner · Research Triangle Institute · R01 · FY2015 · DA
Network and circuit dynamics supporting dopaminergic control of sudden insight learning
$811,112Mazen A Kheirbek · University Of California, San Francisco · R01 · FY2025 · DA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder
$810,889Elena Molokanova · Neurano Bioscience · R44 · FY2025 · DA
Enhancing the quality of CBT in community mental health through AI-generated fidelity feedback
$810,832David Charles Atkins · Lyssn.Io, Inc. · R42 · FY2022 · MH
Neuroimaging of animal models of neurologic and psychiatric disorders
$810,744Yihong Yang · National Institute On Drug Abuse · ZIA · FY2016 · DA
Animal MRI/MRS Methodological Development for Drug Addiction Applications
$810,744Yihong Yang · National Institute On Drug Abuse · ZIA · FY2016 · DA
Next-gen sequencing: searching for mechanisms of alcohol and nicotine dependence
$810,738R. Dayne Mayfield · University Of Texas At Austin · RC2 · FY2009 · AA
Prevention of Neonatal Abstinence Syndrome
$810,655Gary A Peltz · Stanford University · R01 · FY2016 · HD
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
$810,578Francesca Beaudoin · Brown University · R01 · FY2022 · DA
Medication Development for Protracted Abstinence in Alcoholism
$810,499Barbara J Mason · Scripps Research Institute, The · R01 · FY2008 · AA
CSIA-Center for the Study of Impulsivity in Addiction
$810,404Kelvin O. Lim · University Of Minnesota · P20 · FY2009 · DA
Center for Metabolic Research on HIV and Drug Use
$810,288Sherwood L Gorbach · Tufts University Boston · P30 · FY2010 · DA